Clinical trials
Anemia clinical trials
Below are recruiting anemia clinical trials, each written for real people, not researchers. We’re tracking 257 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06213402Recruiting
European registry for rare anemia disorders
This study is creating a European registry (database) to collect information about people with rare anemia disorders. By joining, you help researchers better understand these conditions and improve care for yourself and others.
Barcelona, CataloniaAges birth–100 years - NCT05929729RecruitingPhase 4
Brain study in women with iron deficiency anemia
This is a study that looks at how iron deficiency anemia may affect the brain, and it also checks whether giving iron through an IV is safe and helpful for some participants. You may be in an observation-only group or an iron-treatment group, depending on study testing.
Duarte, CaliforniaAges 16–60 - NCT07811765Recruiting
Iron treatment before vs during early pregnancy
This study compares starting iron supplements before pregnancy versus waiting until the first trimester (first 3 months) to treat iron deficiency anemia. It aims to see which timing better improves health for mothers and babies.
Zhaotong, YunnanAges 18–45 - NCT07206095Recruiting
Better diagnosis for inherited red blood cell diseases
This trial aims to improve how doctors diagnose rare inherited anemias, including sickle cell disease and other conditions that destroy red blood cells. It may help if you have a confirmed or suspected diagnosis but need more clarity through advanced testing.
Barcelona, BarcelonaAges Any age - NCT07019038Recruiting
Autoimmune hemolytic anemia long-term study
This study looks at people with autoimmune hemolytic anemia (AIHA) over time. It aims to understand the disease better and find ways to improve care.
Tianjin, Tianjin MunicipalityAges Any age - NCT05146726Recruiting
Finding the best care for low blood before planned surgery
This study looks at how to detect and treat pre-surgery anemia (low hemoglobin/low blood level) in people having planned operations where blood transfusion is likely. Some participants may also use a machine that collects and returns their own blood during surgery to reduce the need for donor blood.
BerlinAges 18 years+ - NCT06637137Recruiting
Blood management for cardiac surgery patients
This trial studies a program to manage blood levels before, during, and after heart surgery. It may help reduce the need for blood transfusions and improve recovery.
RomaAges 18 years+ - NCT05924100RecruitingPhase 2
Luspatercept for lower red blood counts in MDS with del5q
This Phase 2 trial studies luspatercept to improve anemia (low red blood cells) in people with MDS that has a del5q change. It also checks safety, especially for people who need red blood cell transfusions and have not benefited from prior standard treatments.
AlessandriaAges 18 years+ - NCT07578675Recruiting
Brain Activity Patterns in Anemia Patients
This study uses a non-invasive brain imaging tool to understand how anemia affects thinking and brain function. Researchers hope to learn more about why some anemia patients experience cognitive problems and how to help them.
Tianjin, Tianjin MunicipalityAges 18–65 - NCT07523646RecruitingPhase 4
Blood Boost for Patients With Heart Valve Infections
This study tests whether giving iron and a blood-boosting medicine (EPO) helps patients with bacterial heart valve infections who have low red blood cells. The goal is to see if it speeds recovery and improves how patients feel.
CopenhagenAges 18 years+ - NCT07368972RecruitingPhase 2
Study of DISC-0974-201 for IBD and Anemia
This trial tests a new medicine called DISC-0974-201 for people with inflammatory bowel disease and anemia. It aims to see if the drug can improve anemia symptoms and is for people with mild disease activity who have not responded well to standard treatments.
Birmingham, AlabamaAges 18 years+ - NCT07299123Enrolling by invitationPhase 1/Phase 2
Stem cell transplant with cord cells for severe aplastic anemia
This trial tests a new way to treat severe aplastic anemia by combining a stem cell transplant from a half-matched donor with special stem cells from umbilical cord blood. The goal is to help your body make healthy blood cells again.
BeijingAges 6–60 - NCT07135635Enrolling by invitation
Anemia in pregnancy and baby's brain blood flow
This study uses a special ultrasound (Doppler) to measure blood flow to your baby's brain during the third trimester. The goal is to see how anemia might affect your baby's health and birth outcomes.
SohagAges Any age - NCT07083492Recruiting
Detecting iron deficiency in pregnancy and after birth
This study uses a non-invasive test to check for iron deficiency in women during pregnancy and up to 3 months after giving birth. It aims to make detection easier and more comfortable for you.
Würzburg, BavariaAges 18 years+ - NCT07045155RecruitingPhase 4
Study of pegmolesatide for anemia in dialysis patients
This trial tests a new medication, pegmolesatide, to treat anemia in people who have been on dialysis for at least three months. It aims to help improve red blood cell levels without needing as many other anemia treatments.
Beijing, Beijing MunicipalityAges 18–80 - NCT06976918Recruiting
Myelofibrosis and Anemia Research Study
This study follows people with myelofibrosis and anemia who are starting a new treatment. It aims to learn more about the disease and how treatments work in real life.
Multiple LocationsAges 18 years+ - NCT06061393RecruitingPhase 4
Comparing two iron infusions for anemia in pregnancy
This study compares two IV iron treatments (Ferinject and Venofer) for pregnant women with iron deficiency anemia after 24 weeks of pregnancy, to see which works better and is safer.
NahariyaAges 18–50 - NCT04278651RecruitingPhase 4
Early support to treat iron-deficiency anemia in pregnancy
This trial tests whether starting treatment early in pregnancy can improve iron-deficiency anemia. You may be offered study medications and will be monitored to see if your blood counts and symptoms improve.
Philadelphia, PennsylvaniaAges 18–65 - NCT05757310RecruitingPhase 1
Stem cell transplant with lower-intensity chemo for severe aplastic anemia
This Phase 1 trial tests a “lower-intensity” chemotherapy plan followed by a stem cell transplant from a related half-match donor for severe aplastic anemia that has returned or did not respond to prior medicines. It aims to see if this approach is safe and works well enough to help your blood counts recover.
Duarte, CaliforniaAges Up to 75 years - NCT05320198RecruitingPhase 1/Phase 2
Testing DISC-0974 for anemia in myelofibrosis or MDS
This trial tests an investigational drug called DISC-0974 for people with myelofibrosis or certain types of MDS who have low red blood cell counts (anemia). The goal is to see if this treatment can help improve anemia and reduce the need for blood transfusions.
Gilbert, ArizonaAges 18 years+ - NCT03653338RecruitingPhase 1/Phase 2
Bone marrow transplant using donor blood to treat sickle cell
This trial tests a specific type of bone marrow transplant for people with sickle cell disease (or certain other blood disorders) who have had serious complications despite standard care. It aims to see if removing the patient’s immune cells and using a matched donor’s cells can improve outcomes and reduce complications.
Pittsburgh, PennsylvaniaAges 5–40 - NCT00027274Recruiting
Cancer risk in inherited bone marrow failure syndromes
This study looks at why people with inherited bone marrow failure syndromes (rare genetic conditions affecting blood cell production) have higher cancer risk. Researchers want to understand the genetic and medical factors that increase cancer likelihood, which could help doctors monitor and protect affected patients and their families.
Bethesda, MarylandAges 1 day–100 years - NCT05126849RecruitingPhase 2
Stem cell transplant using half-matched donor and cyclophosphamide
This trial tests a stem cell transplant option for children or young adults with severe aplastic anemia that did not respond to prior immune-suppressing treatment. It uses a “half-matched” donor and gives post-transplant cyclophosphamide to help the donor cells work and reduce certain immune reactions.
AmiensAges 3–35 - NCT06250595Recruiting
European rare blood disorder registry
This study is building a registry of people with rare blood diseases. By joining, you help doctors learn more about these conditions and improve future care.
Barcelona, CataloniaAges Up to 100 years
Hear when a new Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Anemia trials by city
Studies with a site in or near these metro areas.
Anemia trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for anemia?
- Yes. Clin2 currently lists 257 recruiting anemia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a anemia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a anemia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.